Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to become rapidly less effective in commercial use as antimicrobial resistance (AMR) increases over time.
Add photos to showcase Adaptive Phage Therapeutics’s culture
Add Adaptive Phage Therapeutics’s values
Share your experience of working at Adaptive Phage Therapeutics
Add jobs to your org chart to show candidates who they’ll work with
Publish company announcements to get more exposure